TET2 mutation does not impact the prognosis of adult acute myeloid leukemia patients receiving a hematopoietic stem cell transplantation in first remission: similar outcome following matched sibling and unrelated versus haploidentical donor transplants in a multi-center retrospective analysis from the Global Committee and the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
TET2 突变不影响接受造血干细胞移植的成年急性髓系白血病患者在首次缓解期的预后：来自欧洲血液和骨髓移植学会全球委员会和急性白血病工作组的多中心回顾性分析显示，同胞相合供者和非亲缘供者移植与单倍体相合供者移植的预后相似。
期刊:Haematologica
影响因子:7.9
doi:10.3324/haematol.2025.287326
Li, Lin; Ye, Yishan; Galimard, Jacques-Emmanuel; Labopin, Myriam; Wu, Depei; Chen, Jia; Kröger, Nicolaus; Passweg, Jakob; Salmenniemi, Urpu; Itäla-Remes, Maija; Poiré, Xavier; Eder, Matthias; Maertens, Johan; Burns, David; Sengeloev, Henrik; Olesen, Gitte; Blaise, Didier; Finke, Jürgen; Gadisseur, Alain; Bazarbachi, Ali; Brissot, Eolia; Nagler, Arnon; Luo, Yi; Shi, Jimin; Mohty, Mohamad; Huang, He; Ciceri, Fabio; Claude Gorin, Norbert Sr
